Latest News

  • PARTNERSHIPS

    17 Mar 2026

    Why Novo Nordisk Is Putting $2 Billion Into a Pill

  • REGULATORY

    12 Mar 2026

    Medicare's GLP-1 Bridge: Who Gets In?

  • INNOVATION

    6 Mar 2026

    Altimmune's Liver Drug Moves Closer to the Finish Line

  • TECHNOLOGY

    4 Mar 2026

    AI Maps Brown Fat Genes for Next-Gen Weight Drugs

From Code to Clinic: AI Biotech Grows Up

Scientist pipetting samples in biotech laboratory

INSIGHTS

2 Mar 2026

AI drug developers face mounting pressure to turn machine learning breakthroughs into real clinical results

Doctor holding prescription bottle while speaking with patient

PARTNERSHIPS

24 Feb 2026

Lilly Deepens AI Push in Obesity Drug Race

US drugmaker expands Nimbus alliance to pursue oral therapy as analysts forecast $100bn market for weight-loss medicines

Scientist using pipette to prepare lab samples in pharmaceutical research facility

INVESTMENT

23 Feb 2026

Another Shot in the Obesity Gold Rush

A $160m funding round propels Alveus into mid-stage trials, as investors hunt for drugs that improve on today’s GLP-1 blockbusters

Gloved hand placing blood sample vial into laboratory test tube rack

MARKET TRENDS

19 Feb 2026

Precision Medicine Rises as Biomarkers Drive Change

A biomarker surge is reshaping Europe’s healthcare market, driving consolidation, stricter regulation, and a push to align diagnostics wit...

Pfizer corporate logo displayed outside office building

PARTNERSHIPS

17 Feb 2026

Pfizer Steps Up Obesity Push With Metsera Deal

US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies

Insilico Medicine office entrance with AI branding and corporate signage

INSIGHTS

16 Feb 2026

AI Drugmaker Targets Obesity Beyond GLP-1

Insilico advances oral GIP candidate, signalling wider competition in weight-loss treatments  

Gloved researcher examining pharmaceutical vial

REGULATORY

12 Feb 2026

FDA Tightens Grip on GLP-1 Copycats

FDA moves against copycat GLP-1 drugs, strengthening approved giants and reshaping the obesity market

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.